MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    atrophy of cranial nerves v and viii is a hallmark of rfc1-related disorder

    C. Lobo, G. Wertheimer, T. Rezende, PC. Matos, L. Branco, J. Silva, F. Borba, O. Barsottini, JL. Pedroso, W. Marques Jr, M. França Jr (Campinas, Brazil)

    Objective: To assess the usefulness of cranial nerves V (CNV) and VIII (CNVIII) atrophy as a neuroradiological sign to differentiate RFC1-related disorder from spinocerebellar ataxias…
  • 2023 International Congress

    Real-life monitoring of Parkinson’s disease tremor: does the non-tremor subtype really exist?

    R. Terranova, L. Evers, D. Soriano, Y. Raykov, M. Little, H. Cagnan, B. Bloem, R. Helmich (Catania, Italy)

    Objective: To quantify daily-life tremor in Parkinson’s disease (PD) using a smartwatch containing a three-axis accelerometer and gyroscope. Background: Objective and continuous evaluation of PD…
  • 2023 International Congress

    Cell-specific MAPT gene expression is preserved in tau cytopathologies in Progressive Supranuclear Palsy

    S. Forrest, S. Lee, N. Nassir, V. Sackmann, I. Martinez-Valbuena1, J. Li, A. Ahmed, L. Ittner, A. Lang, M. Uddin, G. Kovacs (Toronto, Canada)

    Objective: To systematically map and quantify MAPT expression in neurons, astrocytes and oligodendroglia across different brain regions to determine whether cell type and/or regional differences…
  • 2023 International Congress

    Comparison of cognitive , affective and autonomic functions in parkinson’s disease patients with and without freezing of gait and its correlation with PET/CT

    K. Harisankar, S. Mehta, R. Kumar, M. Mohanty, S. Singh, N. Balaini, V. Lal (CHANDIGARH, India)

    Objective: To study and compare the cognitive, affective and autonomic domains in Parkinson’s disease patients with and without freezing of gait and to correlate with…
  • 2023 International Congress

    Narrative review of the efficacy of the efficacy of transcranial magnetic stimulation with patients with Parkinson disease.

    A. Elaraby, M. Shaien (Gizah, Egypt)

    Objective: To evaluate the efficacy of transcranial magnetic stimulation with patients with Parkinson diseases. Background: Parkinson's disease is one of the most common causes of…
  • 2023 International Congress

    Design of a time-to-event study in GBA Parkinson’s Disease patients: Efficacy and safety of BIA 28-6156, an allosteric activator of beta-glucocerobridase (GCase)

    L. Magalhães, M. Fonseca, G. Castilla-Fernández, R. Costa, D. Simon, J. Holenz, N. Mendonça (Coronado, Portugal)

    Objective: To assess the efficacy of BIA 28-6156 in delaying clinically meaningful motor progression in PD patients who have a PD-risk associated variant in the…
  • 2023 International Congress

    SAFE-DBS – A monocentric, randomised, blind evaluation of safinamide in the perioperative period in Parkinsonian patients with deep brain stimulation

    E. Gülke, M. Höfs, H. Pinnschmidt, A. Gulberti, C. Moll, U. Hidding, C. Buhmann, M. Heise, W. Hamel, M. Pötter-Nerger (Hamburg, Germany)

    Objective: This monocentric, randomised, blind study is designed to evaluate the effect of safinamide on motor and neuropsychiatric symptoms in the 3 month perioperative period…
  • 2023 International Congress

    Freezing of gait in Parkinson’s disease with glucocerebrosidase mutations: prevalence, clinical correlates and effect on quality of life

    R. Ou, C. Li, Q. Wei, K. Liu, J. Lin, T. Yang, Y. Xiao, Q. Jiang, Y. Cheng, Y. Hou, L. Zhang, W. Song, X. Chen, X. Lai, H. Shang (Chengdu, China)

    Objective: Mutations in glucocerebrosidase (GBA) can change the phenotype of Parkinson’s disease (PD). This study aimed to explore the clinical characteristics of freezing of gait…
  • 2023 International Congress

    Clinical implication of small vessel disease burden on deep brain stimulation outcome in Parkinson’s disease

    J. Lee, S. Jo, S. Lee, MS. Kim, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aimed to investigate the correlation between the small vessel disease (SVD) burden and the 1-year outcome after the globus pallidus interna (GPi) deep…
  • 2023 International Congress

    Effect of intensive Game-based neurorehabilitation (GBNR) on gait, balance and quality of life (QOL) in Parkinson’s patients: A prospective randomized control study

    R. Savaj, P. Vengurlekar, C. Sankhla, S. Patel (Mumbai, India)

    Objective: To assess changes in the gait, balance and QOL in PD patients subjected to intensive GBNR in comparison with conventional Neurorehabilitation (NR) therapy using…
  • « Previous Page
  • 1
  • …
  • 290
  • 291
  • 292
  • 293
  • 294
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley